Literature DB >> 21629636

Microbial etiology of febrile neutropenia.

Mudshingkar Swati, Nataraj Gita, Baveja Sujata, Jijina Farah, Mehta Preeti.   

Abstract

Bacterial and fungal infections are a major cause of morbidity and mortality among neutropenic patients. The choice of empiric antimicrobial regimen is based on susceptibility pattern of locally prevalent pathogens. From 64 febrile neutropenic patients with clinical sepsis, blood and other appropriate clinical specimens were processed to determine bacterial and fungal spectrum and their antimicrobial susceptibility pattern. Risk factors for developing sepsis were determined by case-control study. 68 organisms were recovered. Fifteen (22.05%) were Gram-positive cocci with predominance of methicillin Sensitive S. aureus (10.29%), 47 (69.11%) were Gram-negative rods with predominance of Klebsiella pneumoniae (30.88%) and four were Non albicans Candida. 81% and 60% of Klebsiella and E. coli were ESBL producers. All species of Candida were sensitive to amphoterecin B and voriconazole. Duration and extent of neutropenia, chemotherapy, immunosuppressive therapy, altered mucosal barriers and presence of central venous lines were statistically significant risk factors for developing sepsis. Gram-negative bacteria were the predominant isolates. The choice of therapy in neutropenic patients should be formulated based on local spectrum of microbes and local and regional resistance patterns.

Entities:  

Keywords:  Aetiology; Febrile neutropenia; Infection; Risk factors

Year:  2010        PMID: 21629636      PMCID: PMC3002059          DOI: 10.1007/s12288-010-0029-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  24 in total

Review 1.  Fever in immunocompromised patients.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

Review 2.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Infect Control Hosp Epidemiol       Date:  2001-04       Impact factor: 3.254

Review 3.  Infectious complications of febrile leukopenia.

Authors:  H Giamarellou; A Antoniadou
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

Review 4.  Infections in the neutropenic patient--new views of an old problem.

Authors:  G R Donowitz; D G Maki; C J Crnich; P G Pappas; K V Rolston
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

5.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.

Authors:  B A Collin; H L Leather; J R Wingard; R Ramphal
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Bacterial infections in terminally ill hospice patients.

Authors:  L Vitetta; D Kenner; A Sali
Journal:  J Pain Symptom Manage       Date:  2000-11       Impact factor: 3.612

7.  Microbiological findings in febrile neutropenia.

Authors:  J Gaytán-Martínez; E Mateos-García; E Sánchez-Cortés; J González-Llaven; L J Casanova-Cardiel; J L Fuentes-Allen
Journal:  Arch Med Res       Date:  2000 Jul-Aug       Impact factor: 2.235

8.  Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.

Authors:  Hilmar Wisplinghoff; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

Review 9.  Infections in patients with hematological cancer: recent developments.

Authors:  Susan N O'Brien; Nicole M A Blijlevens; Tahsine H Mahfouz; Elias J Anaissie
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

10.  Sepsis in neutropenia--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Xaver Schiel; Holger Hebart; Winfried V Kern; Michael G Kiehl; Jens Peter Sölch; Stefan Wilhelm; Helmut Ostermann
Journal:  Ann Hematol       Date:  2003-09-09       Impact factor: 3.673

View more
  7 in total

1.  Response of first-line antibiotic therapy in patients with febrile neutropenia during treatment of hematological disorders.

Authors:  M Taj; R N Qureshi; T Farzana; T S Shamsi; S S Ahmed
Journal:  Indian J Hematol Blood Transfus       Date:  2014-09-12       Impact factor: 0.900

2.  Emerging Anti-Microbial Resistance in Febrile Neutropenia: Is it high time to evaluate quality control measures?

Authors:  Uzma Mahar; Nida Anwar; Naveena Fatima; Jawad Hassan; Tahir Shamsi
Journal:  Pak J Med Sci       Date:  2020 Sep-Oct       Impact factor: 1.088

3.  Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.

Authors:  Mansoor Sirkhazi; Azmi Sarriff; Noorizan Abd Aziz; Fatma Almana; Osama Arafat; Mahmoud Shorman
Journal:  World J Oncol       Date:  2014-12-03

4.  Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia.

Authors:  Balew Arega; Yimtubezinash Woldeamanuel; Kelemework Adane; Abdulaziz A Sherif; Daniel Asrat
Journal:  Infect Drug Resist       Date:  2018-09-18       Impact factor: 4.003

5.  Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients.

Authors:  Kuntegowdanahalli C Lakshmaiah; Abhayakumar S Malabagi; Rachan Shetty; Mahua Sinha; Rudrapatna S Jayashree
Journal:  J Lab Physicians       Date:  2015 Jul-Dec

Review 6.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

7.  Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years.

Authors:  K Govind Babu; D Lokanatha; K C Lakshmaiah; M C Suresh Babu; Linu A Jacob; Gita R Bhat; Harsha Vardhana; Mahua Sinha; B R Vijaykumar; B G Sumati; R S Jayshree
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.